Resveratrol significantly improves cell survival in comparison to dexrazoxane and carvedilol in a h9c2 model of doxorubicin induced cardiotoxicity

Publication date: August 2021Source: Biomedicine & Pharmacotherapy, Volume 140Author(s): David S. Monahan, Eimhear Flaherty, Aamir Hameed, Garry P. Duffy
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research